In fact, increased expression of NACC1 was found to be associated with disease aggressiveness, development of chemoresistance, and tumor recurrence in several types of human cancer, including ovarian, endometrial, and cervical carcinomas [14,30,31,32,33,34,35,36,37]. Here, NACC1 is linked to cancer.